Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Diabetes Mellitus and CYP3A4[original query] |
|---|
| Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance. Clinical pharmacokinetics 2005 44 (12): 1209-25. Kirchheiner Julia, Roots Ivar, Goldammer Mark, Rosenkranz Bernd, Brockmöller Jürg |
| Association of polymorphisms of ABCA1 and ROS1 with hypertension in Japanese individuals. International journal of molecular medicine 2008 Jan 21 (1): 83-9. Yamada Yoshiji, Kato Kimihiko, Yoshida Tetsuro, Yokoi Kiyoshi, Matsuo Hitoshi, Watanabe Sachiro, Ichihara Sahoko, Metoki Norifumi, Yoshida Hidemi, Satoh Kei, Aoyagi Yukitoshi, Yasunaga Akitomo, Park Hyuntae, Tanaka Masashi, Nozawa Yoshino |
| Association of a polymorphism of CYP3A4 with type 2 diabetes mellitus. International journal of molecular medicine 2007 Nov 20 (5): 703-7. Yamada Yoshiji, Matsuo Hitoshi, Watanabe Sachiro, Kato Kimihiko, Yajima Kazuhiro, Hibino Takeshi, Yokoi Kiyoshi, Ichihara Sahoko, Metoki Norifumi, Yoshida Hidemi, Satoh Kei, Nozawa Yoshino |
| CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation. Pharmacogenomics 2008 Sep 9 (9): 1251-9. Geisler Tobias, Schaeffeler Elke, Dippon Juergen, Winter Stefan, Buse Verena, Bischofs Christian, Zuern Christine, Moerike Klaus, Gawaz Meinrad, Schwab Matthi |
| Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers. European journal of clinical pharmacology 2011 Jul 67 (7): 701-7. He Jiake, Qiu Zhixia, Li Ning, Yu Yang, Lu Yang, Han Deen, Li Tingting, Zhao Di, Sun Wei, Fang Fang, Zheng Jianheng, Fan Hongwei, Chen Xiji |
| CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients. Chinese medical journal 2012 Dec 125 (23): 4233-8. Wang Yu-Yuan, Zhang Ming, Lu Fu-Ming, Jiao Zheng, Qiu Xiao-Y |
| Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. Xenobiotica; the fate of foreign compounds in biological systems 2013 Jan . Chitnis SD, Ogasawara K, Schniedewind B, Gohh RY, Christians U, Akhlaghi F |
| Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients. Pharmacogenetics and genomics 2014 Dec 24 (12): 597-606. Kuypers Dirk R J, de Loor Henriette, Naesens Maarten, Coopmans Tamara, de Jonge Hyl |
| Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2016 Aug . Yi Xingyang, Zhou Qiang, Wang Chun, Lin Jing, Cheng Wen, Chi Lif |
| Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite. European journal of clinical pharmacology 2017 Sep . Danielak Dorota, Kara?niewicz-?ada Marta, Komosa Anna, Burchardt Pawe?, Lesiak Maciej, Kruszyna ?ukasz, Graczyk-Szuster Agnieszka, G?ówka Francisz |
| Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population. Oncotarget 2017 Sep 8 (41): 70811-70820. Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Ju, Zhou Qia |
| Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results. European review for medical and pharmacological sciences 2020 Jan 24 (1): 469-477. Licito A, Marotta G, Battaglia M, Benincasa G, Mentone L, Grillo M R, De Lucia V, Leonardi G, Bignucolo A, Comello F, Di Francia R, De Lucia |
| Influence of FMO3 and CYP3A4 Polymorphisms on the Pharmacokinetics of Teneligliptin in Humans. Frontiers in pharmacology 2021 9 12 736317. Park Jin-Woo, Kim Kyoung-Ah, Kim Jong-Min, Park In-Hwan, Park Ji-You |
| Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients. Frontiers in pharmacology 2021 12 12 726784. Srinivas Lekshmy, Gracious Noble, Nair Radhakrishnan |
| Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients. Pharmacogenomics and personalized medicine 2021 14 1463-1474. Cheng Fang, Li Qiang, Wang Jinglin, Hu Min, Zeng Fang, Wang Zhendi, Zhang |
| CYP3A and CYP2B6 Genotype Predicts Glucose Metabolism Disorder among HIV Patients on Long-Term Efavirenz-Based ART: A Case-Control Study. Journal of personalized medicine 2022 Jun 12 (7): . Tadesse Wondmagegn Tamiru, Mlugu Eulambius Mathias, Shibeshi Workineh, Degu Wondwossen Amogne, Engidawork Ephrem, Aklillu Ele |
| Tacrolimus and Diabetes in Kidney Transplantation: The Impact of Cyp3a5 Gene Polymorphism. Transplantation proceedings 2023 10 . Siyu Liang, Xiaoqiu Zhu, Ruiming Cai, Baomei Yan, Weixiang Liang, Mingjin Cai, Pengfeng Ya |
| Impact of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation. British journal of clinical pharmacology 2023 1 . Hirai Toshinori, Morikawa Yoshihiko, Onishi Ritsuki, Nakatani Yusuke, Nishikawa Kouhei, Inoue Takahiro, Iwamoto Taku |
| The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events. The pharmacogenomics journal 2024 1 24 (1): 3. Amani Abderahmene, Yassine Khalij, Amira Moussa, Meriam Ammar, Amel Ellouz, Dorra Amor, Houwaida Abbes, Mohamed Rayen Ganouni, Wissal Sahtout, Saoussen Chouchene, Asma Omezzine, Dorsaf Zellama, Ali Bousla |
- Page last reviewed:Feb 1, 2024
- Content source: